Montelukast Tablets 5mg
Montelukast is indicated for the treatment of asthma as add-on therapy in patients with mild to moderate persistent asthma who are not adequately controlled with inhaled corticosteroids and in whom "as-needed" short-acting ß-agonists provide insufficient asthma control. Montelukast can also be an alternative treatment option to low-dose inhaled corticosteroids for patients aged 2 to 14 years with mild persistent asthma who do not have a recent history of severe asthma attacks requiring oral corticosteroids and have demonstrated an inability to use inhaled corticosteroids.
Pharmaceutical form
Tablet
Concentration
5mg
Combination
N/A
Disclaimer: The content of this website is for pharmaceutical industry professionals interested in creating a strategic alliance with Wexford Laboratories. This page may contain information related to health, medical conditions, physical condition and its treatment. The information contained in this site is not to diagnose a health problem and is not a substitute for the advice provided by your doctor. Always consult a doctor when in doubt about a disease and its treatment. The products are subject to the applicable patent and registration laws of each country, and may not be allowed to be registered in some markets.
